Trisalus reiterates 2026 revenue guidance of $54M-$57M as CMS G-code expands TriNav reimbursement into office-based labs (NASDAQ:TLSI)
· seekingalpha.com
TriSalus (TLSI) Q2 2026 earnings call recap: $11.4M revenue, CMS G-code expands TriNav reimbursement to OBLs, guidance upheld, FDA risk—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...